UY31410A1 - Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado - Google Patents

Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado

Info

Publication number
UY31410A1
UY31410A1 UY31410A UY31410A UY31410A1 UY 31410 A1 UY31410 A1 UY 31410A1 UY 31410 A UY31410 A UY 31410A UY 31410 A UY31410 A UY 31410A UY 31410 A1 UY31410 A1 UY 31410A1
Authority
UY
Uruguay
Prior art keywords
fatty acids
composition
vegetable carbon
bad
activated vegetable
Prior art date
Application number
UY31410A
Other languages
English (en)
Inventor
Kabaradjian Catherine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31410A1 publication Critical patent/UY31410A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a una composicion oral sin mal aroma, mal olor o mal sabor que comprende ácidos grasos poliinsaturados (PUFA) y carbon vegetal activado, su procedimiento de preparacion y su uso como suplemento nutricional o como suplemento dietético para equilibrar el nivel de lípidos en sangre, prevenir o reducir el riesgo de desarrollo de cambios, trastornos o enfermedades ateroscleroticos.
UY31410A 2007-10-30 2008-10-20 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado UY31410A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07291306 2007-10-30

Publications (1)

Publication Number Publication Date
UY31410A1 true UY31410A1 (es) 2009-05-29

Family

ID=40344798

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31410A UY31410A1 (es) 2007-10-30 2008-10-20 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado

Country Status (15)

Country Link
US (1) US20100260893A1 (es)
EP (1) EP2214638B1 (es)
AR (1) AR070759A1 (es)
AT (1) ATE541560T1 (es)
AU (1) AU2008317920B2 (es)
BR (1) BRPI0818568A2 (es)
CA (1) CA2703816C (es)
ES (1) ES2379034T3 (es)
MX (1) MX2010003703A (es)
PE (1) PE20091076A1 (es)
PL (1) PL2214638T3 (es)
RU (1) RU2485940C2 (es)
TW (1) TW200942229A (es)
UY (1) UY31410A1 (es)
WO (1) WO2009056247A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
CA2803980A1 (en) * 2010-07-01 2012-01-05 Delante Health As Coated effervescent tablet
WO2013070856A1 (en) * 2011-11-09 2013-05-16 Denovo Inc. Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract
RU2524358C2 (ru) * 2012-07-24 2014-07-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
EP2994165A4 (en) * 2013-05-10 2017-01-04 Nitromega Corp. Nutritional or dietary supplements containing fatty acids and nitrite
EA025006B1 (ru) * 2013-08-22 2016-11-30 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105935145B (zh) * 2015-12-18 2019-09-20 重庆两江药物研发中心有限公司 一种鱼油植物甾醇复合片剂及其制备方法
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法
US20200015500A1 (en) * 2016-12-15 2020-01-16 Dsm Ip Assets B.V. Blend formulation comprising silicate and microbial and / or plant cells comprising a polyunsaturated fatty acid having at least 20 carbon atoms (lc-pufa)
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0892587A (ja) 1994-09-22 1996-04-09 Baiotsukusu:Kk 魚臭のマスキング法
JP3534881B2 (ja) 1995-02-23 2004-06-07 太陽化学株式会社 乳化組成物
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
WO1998036745A2 (en) * 1997-02-21 1998-08-27 Abbot Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
ATE301401T1 (de) * 2000-05-18 2005-08-15 Mega Healthcare As Q Nahrungsergänzungsmittel mit vitaminen, mineralien und mehrfach ungesättigten fettsäuren
JP2002204656A (ja) 2001-01-10 2002-07-23 Yakult Honsha Co Ltd 発酵乳飲食品及びその製造方法
DE20105126U1 (de) * 2001-03-23 2002-01-31 Bartz Volker Fischöl zur oralen Einnahme
MXPA03011966A (es) * 2001-06-25 2004-03-26 Pharmacia Corp Metodo y dispositivo para producir tabletas revestidas por compresion.
US6946451B2 (en) * 2002-02-04 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Insulin secretion promoter
AU2003259904A1 (en) 2002-08-14 2004-03-03 E.I. Du Pont De Nemours And Company Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles
WO2004026950A2 (en) * 2002-08-14 2004-04-01 E.I. Du Pont De Nemours And Company Solid flowable powder with high liquid loading
WO2005029978A1 (en) 2003-09-26 2005-04-07 Nestec S.A. Nutritional composition with unsaturated fatty acids and trace elements
DE602004001969T2 (de) * 2004-02-20 2007-03-15 Mattern, Udo Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
JP2009502680A (ja) * 2005-08-03 2009-01-29 サソール テクノロジー（プロプライエタリー）リミテッド 巨大容器の輸送および据付け
GB0516069D0 (en) * 2005-08-04 2005-09-14 Imp College Innovations Ltd Pharmaceutical and use thereof

Also Published As

Publication number Publication date
ATE541560T1 (de) 2012-02-15
TW200942229A (en) 2009-10-16
PE20091076A1 (es) 2009-07-25
BRPI0818568A2 (pt) 2015-04-22
MX2010003703A (es) 2010-07-30
RU2010121714A (ru) 2011-12-10
EP2214638A1 (en) 2010-08-11
AR070759A1 (es) 2010-05-05
ES2379034T3 (es) 2012-04-20
CA2703816C (en) 2016-07-19
CA2703816A1 (en) 2009-05-07
PL2214638T3 (pl) 2012-06-29
WO2009056247A1 (en) 2009-05-07
US20100260893A1 (en) 2010-10-14
AU2008317920A1 (en) 2009-05-07
RU2485940C2 (ru) 2013-06-27
EP2214638B1 (en) 2012-01-18
AU2008317920B2 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
UY31410A1 (es) Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
UY31411A1 (es) Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados
Tapia et al. Comparative study of the nutritional and bioactive compounds content of four walnut (Juglans regia L.) cultivars
Tasset-Cuevas et al. Protective effect of borage seed oil and gamma linolenic acid on DNA: in vivo and in vitro studies
EA201071206A1 (ru) Композиции, содержащие липид, и способы их применения
WO2007092509A3 (en) Dietary supplement composition for blood lipid health
WO2010149895A3 (fr) Extrait de graines entieres de moringa sp et son utilisation dans des compositions cosmetiques et/ou dermatologiques
GB2459809A (en) Fatty acid formulations and methods of use thereof
EA201000400A1 (ru) Твердые жировые композиции, содержащие полиненасыщенные жирные кислоты, и способы их получения и использования
GT201200056A (es) Conjugados de niacina y ácidos grasos y sus usos
EP2946784A3 (en) A therapeutic composition comprising salmon oil and extracts of rosemary and oregano
CR9880A (es) Mezcla de sales de hierro y cobre que enmascaran el sabor metalico
AR051420A1 (es) Procesos para la preparacion de composiciones oleosas
WO2009037562A3 (en) Nutritional supplement formulations and fortified foods comprising such supplements
WO2010136900A3 (en) Methods of using krill oil to treat risk factors for metabolic disorders and obesity
MX2010006130A (es) Producto alimenticio que incluye uno o mas acidos grasos omega-3 y uno o mas sabores de fruta.
Khan et al. Biochemical characterization of Mustard Oil (Brassica campestris L.) with special reference to its fatty acid composition
BR112012007166A2 (pt) "composição de gordura alimentícia, método de uso de ácido estearidônico para formar uma composição de gordura alimentícia,composições alimentícias, manteiga de nozes e metodo para usar ácido esteardônico para formar uma manteiga de nozes.
FR2899768A1 (fr) Complement alimentaire antioxydant contenant des oligoproanthocyanides, du gamma-tocopherol, des catechines et biflavanes, de l'acide carnosique et du carnosol
CO6341531A2 (es) Producto alimenticio de acidos grasos con base de chia, rico en omega-3, con buena estabilidad
MX2016003619A (es) Composicion de grasa comestible.
Benites et al. Physiochemical characterization of soybean oil deodorizer distillate
MX2016008287A (es) Composicion que comprende sacarato ferrico y concentraciones altas de lc-pufa microencapsulado con un sabor desagradable reducido.
MX2010006129A (es) Producto alimenticio que incluye uno o mas acidos grasos omega-3 encapsulados y uno o mas sabores de fruta.
Mataix et al. Virgin olive oil: a key healthy component of the Mediterranean diet

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20171024